Progress in molecular-based management of differentiated thyroid cancer
作者： Mingzhao Xing , Bryan R Haugen , Martin Schlumberger
DOI: 10.1016/S0140-6736(13)60109-9
关键词: Medicine 、 Thyroid nodules 、 Thyroid cancer 、 Internal medicine 、 Genetic testing 、 Regimen 、 Clinical trial 、 Pathology 、 Oncology 、 Carcinoma 、 Thyroid 、 Translational research
摘要: … regimen for patients with thyroid cancer in the near future. … thyroid nodules and thyroid cancer are the most exciting developments in this unprecedented era of molecular thyroid-cancer …
elsevier.com
sci-hub.se 参考文章(127)
Tae Hyuk Kim, Young Joo Park, Jung Ah Lim, Hwa Young Ahn, Eun Kyung Lee, You Jin Lee, Kyung Won Kim, Seo Kyung Hahn, Yeo Kyu Youn, Kwang Hyun Kim, Bo Youn Cho, Do Joon Park, The association of the BRAFV600E mutation with prognostic factors and poor clinical outcome in papillary thyroid cancer Cancer. ,vol. 118, pp. 1764- 1773 ,(2012) , 10.1002/CNCR.26500
Henry Burch, Nicole Hayre, Bertrand Saunier, Kenneth D. Burman, Matthew D. Ringel, Leonard D. Kohn, Motoyasu Saji, Frank Schuppert, Jun Saito, Victor Bernet, Overexpression and Overactivation of Akt in Thyroid Carcinoma Cancer Research. ,vol. 61, pp. 6105- 6111 ,(2001)
S. I. Sherman, B. Jarzab, M. E. Cabanillas, L. F. Licitra, F. Pacini, R. Martins, B. Robinson, D. Ball, J. McCaffrey, M. H. Shah, D. Bodenner, R. Allison, K. Newbold, R. Elisei, J. P. O'Brien, M. Schlumberger, A phase II trial of the multitargeted kinase inhibitor E7080 in advanced radioiodine (RAI)-refractory differentiated thyroid cancer (DTC). Journal of Clinical Oncology. ,vol. 29, pp. 5503- 5503 ,(2011) , 10.1200/JCO.2011.29.15_SUPPL.5503
Donald SA McLeod, Anna M Sawka, David S Cooper, Controversies in primary treatment of low-risk papillary thyroid cancer The Lancet. ,vol. 381, pp. 1046- 1057 ,(2013) , 10.1016/S0140-6736(12)62205-3
Anna M. Sawka, James D. Brierley, Richard W. Tsang, Lehana Thabane, Lorne Rotstein, Amiram Gafni, Sharon Straus, David P. Goldstein, An Updated Systematic Review and Commentary Examining the Effectiveness of Radioactive Iodine Remnant Ablation in Well-Differentiated Thyroid Cancer Endocrinology and Metabolism Clinics of North America. ,vol. 37, pp. 457- 480 ,(2008) , 10.1016/J.ECL.2008.02.007
M. Schlumberger, Prise en charge des cancers réfractaires de la thyroïde Annales D Endocrinologie. ,vol. 72, pp. 149- 157 ,(2011) , 10.1016/J.ANDO.2011.03.020
Carolina Ferraz, Markus Eszlinger, Ralf Paschke, Current state and future perspective of molecular diagnosis of fine-needle aspiration biopsy of thyroid nodules. The Journal of Clinical Endocrinology and Metabolism. ,vol. 96, pp. 2016- 2026 ,(2011) , 10.1210/JC.2010-2567
Rossella Elisei, Clara Ugolini, David Viola, Cristiana Lupi, Agnese Biagini, Riccardo Giannini, Cristina Romei, Paolo Miccoli, Aldo Pinchera, Fulvio Basolo, BRAF(V600E) mutation and outcome of patients with papillary thyroid carcinoma: a 15-year median follow-up study. The Journal of Clinical Endocrinology and Metabolism. ,vol. 93, pp. 3943- 3949 ,(2008) , 10.1210/JC.2008-0607
Anna Guerra, Maria Rosaria Sapio, Vincenzo Marotta, Elisabetta Campanile, Maria Ilaria Moretti, Maurilio Deandrea, Manuela Motta, Paolo Piero Limone, Gianfranco Fenzi, Guido Rossi, Mario Vitale, Prevalence of RET/PTC rearrangement in benign and malignant thyroid nodules and its clinical application Endocrine Journal. ,vol. 58, pp. 31- 38 ,(2011) , 10.1507/ENDOCRJ.K10E-260
Ji-Yong Joo, Jae-Yong Park, Yeo-Hoon Yoon, Bobae Choi, Jin-Man Kim, Young Suk Jo, Minho Shong, Bon Seok Koo, None, Prediction of occult central lymph node metastasis in papillary thyroid carcinoma by preoperative BRAF analysis using fine-needle aspiration biopsy: a prospective study. The Journal of Clinical Endocrinology and Metabolism. ,vol. 97, pp. 3996- 4003 ,(2012) , 10.1210/JC.2012-2444